Neuralink Aims for High-Volume Production and Fully Automated Brain Chip Implants by 2026
Elon Musk has announced that Neuralink, his brain-chip startup, will begin high-volume production of its brain-computer interface devices in 2025, with plans to fully automate the implantation procedure by 2026. In a Tuesday post on X, Musk confirmed the company’s shift toward mass production, marking a major step in its mission to develop neural implants that connect the human brain directly to computers. Neuralink, co-founded by Musk in 2016, is focused on creating implantable devices that allow people to control digital systems using their thoughts. The initial target is patients with severe neurological conditions, including paralysis, Parkinson’s disease, Alzheimer’s, and visual impairments, aiming to restore communication and independence. The device itself is about the size of a coin. It features an array of ultra-thin, flexible threads—each 20 times thinner than a human hair—that are inserted into the brain to record and transmit neural signals. Traditionally, the implantation process required a surgeon to remove a section of the skull before a robotic arm placed the chip. However, Musk now says the procedure will be transformed into a streamlined, nearly fully automated process by 2026, with the device threads passing through the dura mater—the protective membrane surrounding the brain—without removing it. “This is a big deal,” Musk wrote in a follow-up post on Thursday, underscoring the significance of the advancement. The new method could dramatically reduce surgical risk, time, and cost, making the technology more accessible. Noland Arbaugh, a quadriplegic who became Neuralink’s first human patient in January 2024, has spoken publicly about how the implant has helped him regain control over digital devices and reconnect with others, describing it as life-changing. By September 2025, Neuralink reported that 12 people globally had received implants and were actively using them. Musk has previously stated the company aims to treat over a thousand patients with the device by 2026. To support this goal, Neuralink launched a major hiring campaign in November 2024, seeking manufacturing technicians, microfabrication experts, and engineers to scale up production. While the company’s near-term focus remains on medical applications, Musk has long envisioned a future where such implants help merge human intelligence with artificial intelligence, potentially enabling new levels of cognitive enhancement and human-machine integration.
